Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.5%

3 terminated/withdrawn out of 40 trials

Success Rate

85.0%

-1.5% vs industry average

Late-Stage Pipeline

23%

9 trials in Phase 3/4

Results Transparency

12%

2 of 17 completed trials have results

Key Signals

8 recruiting2 with results

Enrollment Performance

Analytics

Phase 2

9(32.1%)

Phase 3

9(32.1%)

N/A

7(25.0%)

Phase 1

3(10.7%)

28Total

Phase 2(9)

Phase 3(9)

N/A(7)

Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (40)

Showing 20 of 40 trials

NCT03654105Phase 2Active Not Recruiting

Screening and Multiple Intervention on Lung Epidemics

Role: collaborator

NCT06832644Not ApplicableRecruiting

Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)

Role: collaborator

NCT07274384Phase 2Not Yet Recruiting

Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial

Role: collaborator

NCT04776655Phase 3Recruiting

Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB

Role: collaborator

NCT05150704Phase 3Recruiting

MYTHS - MYocarditis THerapy With Steroids

Role: collaborator

NCT05756621Recruiting

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

Role: collaborator

NCT02596126Phase 3Completed

Secondary Prevention of Cardiovascular Disease in the Elderly Trial

Role: collaborator

NCT05339841Not ApplicableActive Not Recruiting

Italian Digital Primary Cardiovascular Prevention Study

Role: collaborator

NCT05014581Phase 3Recruiting

Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation

Role: collaborator

NCT03654001Phase 3Completed

ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)

Role: collaborator

NCT05601700Phase 3Recruiting

Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

Role: collaborator

NCT06513299Active Not Recruiting

Effectiveness of Low Volume and Low Pressure in Severe Hypoxemic Patients

Role: collaborator

NCT04400981Not ApplicableCompleted

Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies

Role: collaborator

NCT04747990Completed

coMpliAnce With evideNce-based cliniCal Guidelines in the managemenT of Acute biliaRy pancreAtitis

Role: collaborator

NCT02585622Phase 1Terminated

NEPHSTROM for Diabetic Kidney Disease

Role: collaborator

NCT04257513Completed

Clinical Study to Monitor Plasma Levels of 24OHC in Subject with HD

Role: collaborator

NCT06337019Recruiting

The Italian Registry of Malnutrition in Oncology

Role: collaborator

NCT06325943Phase 3Completed

Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Role: collaborator

NCT04460807Phase 3Terminated

Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Role: collaborator

NCT06163833Phase 2Recruiting

Mesenchymal Stromal Cells for Traumatic Brain Injury

Role: collaborator